MAPT and Alzheimer disease: Furthermore, our finding of reduced NMNAT2 expression parallels previous work showing that NMNAT2 overexpression reduces Aβ production and tau phosphorylation in Tg2576 mice (Cheng et al., 2013, 2021), suggesting that its downregulation in astrocytes may contribute to AD pathology.